• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝炎的综合生活方式干预-基于大豆蛋白的膳食方案。

Comprehensive lifestyle intervention soy protein-based meal regimen in non-alcoholic steatohepatitis.

机构信息

Faculty of Medicine, Department of Medicine, Institute of Exercise and Occupational Medicine, Medical Center, University of Freiburg, Freiburg D-79106, Germany.

Department of Nutrition, Institute for Sports and Sports Science, University of Freiburg, Freiburg D-79106, Germany.

出版信息

World J Gastroenterol. 2019 Mar 7;25(9):1116-1131. doi: 10.3748/wjg.v25.i9.1116.

DOI:10.3748/wjg.v25.i9.1116
PMID:30862999
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6406181/
Abstract

BACKGROUND

Non-alcoholic steatohepatitis (NASH) has become one of the leading causes of liver disease in the western world. In obese patients weight reduction is recommended. Up to now there are no specific guidelines for weight loss in order to reduce hepatic fat content.

AIM

To investigate the effects of a 24-wk guided lifestyle intervention program compared to a meal replacement regimen based on soy protein.

METHODS

Twenty-six subjects with NASH participated in a randomized single-center study. They were randomly assigned to either meal replacement group (MR-G) with soy-yogurt-honey preparation or to guided lifestyle change group (LC-G) with endurance activity and nutrition counselling. Serum alanine transaminase (ALT), aspartate transaminase (AST), lipid parameters, and adipokines were measured. Liver fat content and lipid composition were determined by magnetic resonance imaging and magnetic resonance spectroscopy. Body fat mass and lean body mass were assessed using Bod Pod device. Pre- and post-intervention monitoring of parameters was performed. Statistical analyses were conducted with SPSS software, results were expressed as median (interquartile range).

RESULTS

Twenty-two subjects (MR-G, = 11 and LC-G, = 11) completed the study (9 women, 13 men; age 52.1 (15.0) years, body mass index (BMI) 32.3 (3.3) kg/m²). In both groups a significant weight loss was achieved (MR-G: -6.4 (3.6) kg, < 0.01; LC-G: -9.1 (10.4) kg, < 0.01). BMI dropped in both groups (MR-G: -2.3 (1.5) kg/m, = 0.003; LC-G: -3.0 (3.4) kg/m, = 0.006). Internal fat and hepatic lipid content were markedly reduced in both groups in comparable amount. There was a strong correlation between reduction in liver fat and decrease in ALT. Likewise, both groups showed an improvement in glycemic control and lipid profile. Changes in adipokines, particularly in adiponectin and leptin were closely related to intrahepatic lipid changes.

CONCLUSION

Comprehensive lifestyle intervention and meal replacement regimen have comparable effects on body and liver fat, as well as decrease in markers of hepatic inflammation among NASH patients.

摘要

背景

非酒精性脂肪性肝炎(NASH)已成为西方国家肝脏疾病的主要原因之一。在肥胖患者中,建议减轻体重。到目前为止,还没有专门针对降低肝脂肪含量的减肥指南。

目的

调查 24 周指导的生活方式干预与基于大豆蛋白的代餐方案相比对 NASH 的影响。

方法

26 名 NASH 患者参加了一项随机单中心研究。他们被随机分配到代餐组(MR-G),食用大豆酸奶蜂蜜制剂,或指导生活方式改变组(LC-G),进行耐力活动和营养咨询。检测血清丙氨酸转氨酶(ALT)、天冬氨酸转氨酶(AST)、血脂参数和脂肪因子。通过磁共振成像和磁共振波谱测量肝脂肪含量和脂质组成。使用 Bod Pod 设备评估体脂肪量和瘦体重。在干预前后监测参数。使用 SPSS 软件进行统计分析,结果表示为中位数(四分位数范围)。

结果

22 名患者(MR-G, = 11;LC-G, = 11)完成了研究(9 名女性,13 名男性;年龄 52.1(15.0)岁,体重指数(BMI)32.3(3.3)kg/m²)。两组体重均显著减轻(MR-G:-6.4(3.6)kg, < 0.01;LC-G:-9.1(10.4)kg, < 0.01)。两组 BMI 均下降(MR-G:-2.3(1.5)kg/m, = 0.003;LC-G:-3.0(3.4)kg/m, = 0.006)。两组肝内脂肪和肝脂质含量均显著减少,减少量相当。肝脂肪减少与 ALT 降低之间存在很强的相关性。同样,两组患者的血糖控制和血脂谱均得到改善。脂肪因子的变化,特别是脂联素和瘦素的变化与肝内脂质变化密切相关。

结论

综合生活方式干预和代餐方案对 NASH 患者的体脂和肝脂以及肝内炎症标志物的减少具有相当的效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45f0/6406181/86de304d7eb0/WJG-25-1116-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45f0/6406181/4e32a265c05c/WJG-25-1116-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45f0/6406181/c90dfab814ff/WJG-25-1116-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45f0/6406181/a5eece054150/WJG-25-1116-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45f0/6406181/86de304d7eb0/WJG-25-1116-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45f0/6406181/4e32a265c05c/WJG-25-1116-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45f0/6406181/c90dfab814ff/WJG-25-1116-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45f0/6406181/a5eece054150/WJG-25-1116-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45f0/6406181/86de304d7eb0/WJG-25-1116-g004.jpg

相似文献

1
Comprehensive lifestyle intervention soy protein-based meal regimen in non-alcoholic steatohepatitis.非酒精性脂肪性肝炎的综合生活方式干预-基于大豆蛋白的膳食方案。
World J Gastroenterol. 2019 Mar 7;25(9):1116-1131. doi: 10.3748/wjg.v25.i9.1116.
2
Internal Fat and Cardiometabolic Risk Factors Following a Meal-Replacement Regimen vs. Comprehensive Lifestyle Changes in Obese Subjects.代餐方案与全面生活方式改变对肥胖受试者餐后内脏脂肪及心血管代谢危险因素的影响
Nutrients. 2015 Dec 1;7(12):9825-33. doi: 10.3390/nu7125500.
3
A meal replacement regimen improves blood glucose levels in prediabetic healthy individuals with impaired fasting glucose.代餐方案可改善空腹血糖受损的糖尿病前期健康个体的血糖水平。
Nutrition. 2014 Nov-Dec;30(11-12):1306-9. doi: 10.1016/j.nut.2014.03.014. Epub 2014 Mar 31.
4
Comparative effects of liraglutide 3 mg vs structured lifestyle modification on body weight, liver fat and liver function in obese patients with non-alcoholic fatty liver disease: A pilot randomized trial.利拉鲁肽 3 毫克与结构化生活方式改变对肥胖非酒精性脂肪性肝病患者体重、肝脂肪和肝功能的比较影响:一项先导随机试验。
Diabetes Obes Metab. 2017 Dec;19(12):1814-1817. doi: 10.1111/dom.13007. Epub 2017 Jul 14.
5
Weight loss without losing muscle mass in pre-obese and obese subjects induced by a high-soy-protein diet.高大豆蛋白饮食诱导肥胖前期和肥胖受试者体重减轻且不损失肌肉量。
Int J Obes Relat Metab Disord. 2004 Oct;28(10):1349-52. doi: 10.1038/sj.ijo.0802765.
6
Biochemical parameters response to weight loss in patients with non-alcoholic steatohepatitis.非酒精性脂肪性肝炎患者体重减轻后的生化参数反应
Afr Health Sci. 2016 Mar;16(1):242-9. doi: 10.4314/ahs.v16i1.32.
7
Lifestyle intervention for morbid obesity: effects on liver steatosis, inflammation, and fibrosis.生活方式干预治疗病态肥胖:对肝脏脂肪变性、炎症和纤维化的影响。
Am J Physiol Gastrointest Liver Physiol. 2018 Sep 1;315(3):G329-G338. doi: 10.1152/ajpgi.00044.2018. Epub 2018 Jun 7.
8
Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease.生活方式干预对非肥胖非酒精性脂肪性肝病患者的有益影响。
J Hepatol. 2018 Dec;69(6):1349-1356. doi: 10.1016/j.jhep.2018.08.011. Epub 2018 Aug 22.
9
Effect of meal replacement on metabolic risk factors in overweight and obese subjects.代餐对超重和肥胖受试者代谢危险因素的影响。
Ann Nutr Metab. 2008;52(1):74-8. doi: 10.1159/000119416. Epub 2008 Mar 4.
10
Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial.基于地中海生活方式的干预对非酒精性脂肪性肝病患者临床特征的改善:一项随机对照临床试验。
Br J Nutr. 2018 Jul;120(2):164-175. doi: 10.1017/S000711451800137X.

引用本文的文献

1
Meal replacements on obesity and leptin: a systematic review and meta-analysis.代餐对肥胖和瘦素的影响:一项系统评价与荟萃分析
Rev Endocr Metab Disord. 2025 Feb;26(1):55-80. doi: 10.1007/s11154-024-09918-5. Epub 2024 Oct 21.
2
The Effect of Mobile Lifestyle Intervention Combined with High-Protein Meal Replacement on Liver Function in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Pilot Randomized Controlled Trial.移动生活方式干预联合高蛋白代餐对代谢相关脂肪性肝病患者肝功能的影响:一项初步随机对照试验。
Nutrients. 2024 Jul 13;16(14):2254. doi: 10.3390/nu16142254.
3
The effect of soy isoflavones on non-alcoholic fatty liver disease and the level of fibroblast growth factor-21 and fetuin A.

本文引用的文献

1
Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2 Diabetes.热量相同的动物蛋白或植物蛋白饮食可减少 2 型糖尿病患者的肝脏脂肪和炎症。
Gastroenterology. 2017 Feb;152(3):571-585.e8. doi: 10.1053/j.gastro.2016.10.007. Epub 2016 Oct 17.
2
Associations between Dietary Nutrient Intakes and Hepatic Lipid Contents in NAFLD Patients Quantified by ¹H-MRS and Dual-Echo MRI.通过¹H-MRS和双回波MRI定量分析非酒精性脂肪性肝病患者饮食营养摄入与肝脏脂质含量之间的关联。
Nutrients. 2016 Aug 27;8(9):527. doi: 10.3390/nu8090527.
3
Exercise Reduces Liver Lipids and Visceral Adiposity in Patients With Nonalcoholic Steatohepatitis in a Randomized Controlled Trial.
大豆异黄酮对非酒精性脂肪性肝病及成纤维细胞生长因子 21 和胎球蛋白 A 水平的影响。
Sci Rep. 2024 Mar 1;14(1):5134. doi: 10.1038/s41598-024-55747-6.
4
Delivery of a telehealth supported home exercise program with dietary advice to increase plant-based protein intake in people with non-alcoholic fatty liver disease: a 12-week randomised controlled feasibility trial.远程医疗支持的家庭运动计划和饮食建议以增加非酒精性脂肪肝患者植物性蛋白质摄入量:一项为期 12 周的随机对照可行性试验。
Br J Nutr. 2024 May 28;131(10):1709-1719. doi: 10.1017/S0007114524000242. Epub 2024 Jan 25.
5
Non-alcoholic fatty liver disease risk prediction model and health management strategies for older Chinese adults: a cross-sectional study.非酒精性脂肪性肝病风险预测模型及中国老年人群健康管理策略:一项横断面研究。
Lipids Health Dis. 2023 Nov 25;22(1):205. doi: 10.1186/s12944-023-01966-1.
6
The Role of Choline, Soy Isoflavones, and Probiotics as Adjuvant Treatments in the Prevention and Management of NAFLD in Postmenopausal Women.胆碱、大豆异黄酮和益生菌作为辅助治疗在绝经后妇女非酒精性脂肪性肝病的预防和管理中的作用。
Nutrients. 2023 Jun 8;15(12):2670. doi: 10.3390/nu15122670.
7
Lipid accumulation product (LAP) index for the diagnosis of nonalcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis.脂堆积产物(LAP)指数诊断非酒精性脂肪性肝病(NAFLD):系统评价和荟萃分析。
Lipids Health Dis. 2023 Mar 15;22(1):41. doi: 10.1186/s12944-023-01802-6.
8
Effects of lifestyle intervention on adults with metabolic associated fatty liver disease: A systematic review and meta-analysis.生活方式干预对代谢相关脂肪性肝病成人患者的影响:系统评价和荟萃分析。
Front Endocrinol (Lausanne). 2023 Feb 16;14:1081096. doi: 10.3389/fendo.2023.1081096. eCollection 2023.
9
Effects of a Short-Term Meal Replacement Hypocaloric Diet in Subjects with Obesity and High Fatty Liver Index.短期代餐低热量饮食对肥胖和高脂肪肝指数受试者的影响。
Nutrients. 2022 Dec 16;14(24):5353. doi: 10.3390/nu14245353.
10
A soy-yoghurt-honey product as a therapeutic functional food: mode of action and narrative review.一种作为治疗性功能性食品的大豆酸奶蜂蜜产品:作用方式及叙述性综述
Heliyon. 2022 Oct 10;8(11):e11011. doi: 10.1016/j.heliyon.2022.e11011. eCollection 2022 Nov.
一项随机对照试验表明,运动可降低非酒精性脂肪性肝炎患者的肝脏脂质和内脏脂肪含量。
Clin Gastroenterol Hepatol. 2017 Jan;15(1):96-102.e3. doi: 10.1016/j.cgh.2016.07.031. Epub 2016 Aug 10.
4
Effectiveness of exercise in hepatic fat mobilization in non-alcoholic fatty liver disease: Systematic review.运动对非酒精性脂肪性肝病肝脏脂肪动员的有效性:系统评价
World J Gastroenterol. 2016 Jul 21;22(27):6318-27. doi: 10.3748/wjg.v22.i27.6318.
5
Fetuin A is a Predictor of Liver Fat in Preoperative Patients with Nonalcoholic Fatty Liver Disease.胎球蛋白A是术前非酒精性脂肪性肝病患者肝脏脂肪含量的预测指标。
J Invest Surg. 2016 Oct;29(5):266-74. doi: 10.3109/08941939.2016.1149640. Epub 2016 Mar 16.
6
Internal Fat and Cardiometabolic Risk Factors Following a Meal-Replacement Regimen vs. Comprehensive Lifestyle Changes in Obese Subjects.代餐方案与全面生活方式改变对肥胖受试者餐后内脏脂肪及心血管代谢危险因素的影响
Nutrients. 2015 Dec 1;7(12):9825-33. doi: 10.3390/nu7125500.
7
Serum Fetuin-A Associated With Fatty Liver Index, Early Indicator of Nonalcoholic Fatty Liver Disease: A Strobe-Compliant Article.血清胎球蛋白-A与脂肪肝指数相关,非酒精性脂肪性肝病的早期指标:一篇符合STRoBE规范的文章
Medicine (Baltimore). 2015 Sep;94(39):e1517. doi: 10.1097/MD.0000000000001517.
8
Dissociation between exercise-induced reduction in liver fat and changes in hepatic and peripheral glucose homoeostasis in obese patients with non-alcoholic fatty liver disease.非酒精性脂肪性肝病肥胖患者中运动引起的肝内脂肪减少与肝内和外周葡萄糖稳态变化的分离。
Clin Sci (Lond). 2016 Jan;130(2):93-104. doi: 10.1042/CS20150447. Epub 2015 Sep 30.
9
Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis.非酒精性脂肪性肝病中的循环瘦素:一项系统评价和荟萃分析。
Diabetologia. 2016 Jan;59(1):30-43. doi: 10.1007/s00125-015-3769-3. Epub 2015 Sep 26.
10
Value of MRI and MRS fat measurements to complement conventional screening methods for childhood obesity.MRI和MRS脂肪测量对补充儿童肥胖症传统筛查方法的价值。
J Magn Reson Imaging. 2015 Nov;42(5):1214-22. doi: 10.1002/jmri.24919. Epub 2015 Apr 15.